{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:41:19Z","timestamp":1784356879228,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.vaccine.2012.11.027","type":"journal-article","created":{"date-parts":[[2012,11,19]],"date-time":"2012-11-19T16:00:20Z","timestamp":1353340820000},"page":"3396-3402","source":"Crossref","is-referenced-by-count":86,"title":["Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch"],"prefix":"10.1016","volume":"31","author":[{"given":"Sungsil","family":"Moon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Edens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon R.","family":"Gentsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Prausnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.11.027_bib0005","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1473-3099(11)70253-5","article-title":"2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis","volume":"12","author":"Tate","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa052434","article-title":"Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis","volume":"354","author":"Ruiz-Palacios","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Safety and efficacy of a pentavalent human\u2013bovine (WC3) reassortant rotavirus vaccine.[see comment]","volume":"354","author":"Vesikari","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJMoa0904797","article-title":"Effect of human rotavirus vaccine on severe diarrhea in African infants","volume":"362","author":"Madhi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0025","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0140-6736(10)60755-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Zaman","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0030","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4161\/hv.5.6.8176","article-title":"Immunogenicity, reactogenicity and safety of human rotavirus vaccine (RIX4414) in Indian infants","volume":"5","author":"Narang","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0035","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(10)60889-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Armah","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0040","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1001\/jama.2009.756","article-title":"Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua","volume":"301","author":"Patel","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0045","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa1012952","article-title":"Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil","volume":"364","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0050","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.vaccine.2011.01.088","article-title":"Intussusception following rotavirus vaccine administration: post-marketing surveillance in the national immunization program in Australia","volume":"29","author":"Buttery","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0055","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/INF.0b013e3181e232ea","article-title":"Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines","volume":"29","author":"Moon","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0060","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.1016\/j.vaccine.2008.10.008","article-title":"Inactivated rotavirus vaccines: a priority for accelerated vaccine development","volume":"26","author":"Jiang","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0065","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4161\/hv.6.3.10409","article-title":"Molecular characterization of human rotavirus vaccine strain CDC-9 during sequential passages in Vero cells","volume":"6","author":"Esona","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4161\/hv.4.2.5263","article-title":"Immunogenicity of a thermally inactivated rotavirus vaccine in mice","volume":"4","author":"Jiang","year":"2008","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0075","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1016\/j.vaccine.2010.06.006","article-title":"Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets","volume":"28","author":"Wang","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0080","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1016\/j.vaccine.2008.03.095","article-title":"Intradermal vaccine delivery: will new delivery systems transform vaccine administration?","volume":"26","author":"Lambert","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0085","series-title":"Vaccines","first-page":"1200","article-title":"Alternative vaccine delivery methods","author":"Weniger","year":"2013"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0090","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000416834","article-title":"Immunological host defense of the skin","volume":"18","author":"Stingl","year":"1989","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0095","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00130832-200110000-00014","article-title":"Keratinocytes in epidermal immune responses","volume":"1","author":"Steinhoff","year":"2001","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev-chembioeng-073009-100948","article-title":"Transcutaneous immunization: an overview of advantages, disease targets, vaccines, and delivery technologies","volume":"1","author":"Karande","year":"2010","journal-title":"Ann Rev Chem Biomol Eng"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0105","first-page":"247","article-title":"Mass vaccination: solutions in the skin","volume":"304","author":"Glenn","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0110","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/heapro\/dah110","article-title":"Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses","volume":"19","author":"Kermode","year":"2004","journal-title":"Health Promot Int"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nm0103-99","article-title":"Can needle-free administration of vaccines become the norm in global immunization?","volume":"9","author":"Levine","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0120","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nri1728","article-title":"Immunization without needles","volume":"5","author":"Mitragotri","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0125","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1086\/649228","article-title":"Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles","volume":"201","author":"Kim","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0130","doi-asserted-by":"crossref","first-page":"e10266","DOI":"10.1371\/journal.pone.0010266","article-title":"Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model","volume":"5","author":"Fernando","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2009.10.013","article-title":"Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity","volume":"142","author":"Kim","year":"2010","journal-title":"J Control Rel"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0140","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1128\/JVI.76.10.4741-4749.2002","article-title":"Frequencies of virus-specific CD4(+) and CD8(+) T lymphocytes secreting gamma interferon after acute natural rotavirus infection in children and adults","volume":"76","author":"Jaimes","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0145","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1574-695X.2011.00923.x","article-title":"Antigenemia, RNAemia, and innate immunity in children with acute rotavirus diarrhea","volume":"64","author":"Moon","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0150","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0264-410X(98)00317-X","article-title":"Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles","volume":"17","author":"Jiang","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0155","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1172\/JCI0215962","article-title":"Exploiting dendritic cells to improve vaccine efficacy","volume":"109","author":"Steinman","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0160","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nri746","article-title":"Mouse and human dendritic cell subtypes","volume":"2","author":"Shortman","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0165","first-page":"211","article-title":"Immune surveillance in the skin: mechanisms and clinical consequences","volume":"4","author":"Kupper","year":"2004","journal-title":"Nat Rev"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0170","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/eji.1830240710","article-title":"Immunoglobulin isotype regulation by antigen-presenting cells in vivo","volume":"24","author":"De Becker","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2012.11.027_bib0175","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0264-410X(95)98263-A","article-title":"Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in Balb\/c mice that are similar to those generated by experimental infection","volume":"13","author":"Hancock","year":"1995","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12016209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12016209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T04:28:27Z","timestamp":1540096107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12016209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":35,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0264410X12016209"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.11.027","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}